To establish a mouse model of accelerated atherosclerosis in lupus, we generated apolipoprotein E-deficient (apoE 2/2 ) and Fas lpr/lpr (Fas 2/2 ) C57BL/6 mice. On a normal chow diet, 5 month old apoE 2/2 Fas 2/2 mice had enlarged glomerular tuft areas, severe proteinuria, increased circulating autoantibody levels, and increased apoptotic cells in renal and vascular lesions compared with either single knockout mice. Also, double knockout mice developed increased atherosclerotic lesions but decreased serum levels of total and non-HDL cholesterol compared with apoE Cardiovascular complications related to atherosclerosis are common among patients with systemic lupus erythematosus (SLE) and contribute to their disability and death (1-4). Women with SLE between 35 and 44 years old have an estimated 50-fold increased risk of myocardial infarction compared with age-and gender-matched controls (5). After controlling for traditional Framingham risk factors, the relative risk for early coronary heart disease attributed to SLE itself is 7.5-fold (6). An increased prevalence of subclinical atherosclerosis in SLE has also been established: 37% of SLE patients versus 15% of controls have plaques detectable by carotid artery ultrasound (3), and 31% of SLE patients versus 9% of controls exhibit coronary artery calcification (4). The disease processes of SLE itself, including a longer duration of disease, a higher damage-index score, and less aggressive immunosuppressive therapy, are independent risk factors for atherosclerosis (3).Similar to accelerated atherosclerosis in SLE, bone loss in SLE involves both traditional osteoporosis risk factors and lupus-related factors. More than one-third of SLE patients were osteopenic by bone mineral density (BMD) scanning (7,8) More strikingly, at least 20% of SLE patients (mean age of 41 years) had osteoporotic vertebral